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We present the first report of community-acquired human
infections with marine mammal–associated Brucella spp. and
describe the identification of these strains in two patients with
neurobrucellosis and intracerebral granulomas. The identifica-
tion of these isolates as marine mammal strains was based on
omp2a sequence and amplification of the region flanking bp26.
B
rucellosis, caused by intracellular gram-negative bacteria
of the genus Brucella, is endemic in many areas of the
world. Exposure occurs through contact with infected animals,
meat, or unpasteurized milk products. Neurobrucellosis is a
rare, severe form of systemic infection and has a broad range of
clinical syndromes (1–3). Central nervous system Brucella
granulomas have been infrequently reported in sellar and
parasellar sites and in the spinal cord (4–6). 
Although a number of Brucella spp. cause systemic disease
in humans, they have species-specific primary reservoirs. The
six recognized species of Brucella are primarily associated
with terrestrial mammals and rodents. Recently, Brucella has
been found to cause infections in marine mammals (7,8). An
expansion of the six current nomen species of Brucella has
been proposed to include one (B. maris) or two (B. pinnipediae
and B. cetaceae) new nomen species to categorize these strains
(7,8). 
To date, only one human infection with a marine mammal
strain has been reported; this infection occurred in a research
laboratory worker after occupational exposure (9). We present
the first report of community-acquired human infection with
marine mammal–associated Brucella spp. and describe the
identification of these strains from two patients with neurobru-
cellosis and intracerebral granulomas. 
Case Reports
Patient 1
Patient 1 was a previously healthy, 26-year-old Peruvian
man who was evaluated in July 1985 for a 3-month history of
periorbital pain, headaches, and periodic generalized tonic-
clonic seizures. The initial neurologic examination was nonfo-
cal, but subsequent computerized tomography scan showed a
5x5-cm enhancing mass in the left frontoparietal region associ-
ated with midline shift. 
At the time of surgical biopsy, frozen section histology
raised the possibility of a high-grade astrocytoma or lymphoma,
prompting resection of a 3x3-cm well-circumscribed left frontal
lobe mass. Final examination of pathologic specimens showed
granulomas with multinucleated giant cells (Figure 1).
Bacterial, fungal, and acid-fast bacilli stains were negative.
Based on these pathologic findings and concern that the patient
may have had tuberculosis, treatment with isoniazid, rifampin,
and ethambutol was begun. Serologic tests for Histoplasma
capsulatum,  Blastomyces dermatitidis,  Coccidioides immitis,
and Paracoccidioides brasiliensis were negative. Toxoplasma
gondii serologic titers were weakly positive at 1:64.
On postoperative day 39, fungal tissue cultures became pos-
itive for a Brucella spp., preliminarily identified as B. meliten-
sis. The patient’s antimicrobial treatment was changed to tetra-
cycline and rifampin and was continued for 2 months. An ini-
tial serologic titer for Brucella was positive at 1:160 by tube
agglutination assay. A follow-up serologic titer obtained in
January 1986 was negative (<1:20). 
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Figure 1. Hematoxylin and eosin–stained sections from patient 1 (pan-
els A, B) and patient 2 (panels C, D). Note the predominantly lympho-
histocytic infiltrate forming large granulomas (A, original magnification
100x); well-formed giant cells (B, arrow, original magnification 200x);
lymphohistiocytic infiltrates distorting brain parenchyma and forming
vague granulomas (C, original magnification 40x); and the dense
astrogliosis at the interface between granulomatous inflammation and
surrounding brain parenchyma (D, asterisk, original magnification
100x).Three months before his initial evaluation, the patient had
immigrated to the United States from Lima, Peru. His diet
included regular consumption of unpasteurized cow or goat
cheese (queso fresco) and occasional consumption of raw shell-
fish (ceviche). He denied eating other raw or significantly
undercooked meat. He had frequently swum in the Pacific
Ocean from December through March but recalled no direct
contact with marine mammals.
Patient 2
Patient 2 was a 15-year-old Peruvian boy seen in September
2001 with a 1-year history of headaches, nausea, vomiting, and
progressive deterioration in visual function. A magnetic reso-
nance imaging (MRI) scan performed in April 2001 showed
several large, irregular enhancing mass lesions involving the
left occipital and parietal lobes (Figure 2). He had come to the
United States in September for further evaluation. On neuro-
logic examination, the patient had a right homonymous hemi-
anopsia, optic nerve atrophy, and major visual impairment (left
eye—20/100; right eye—20/200). Repeat MRI showed several
irregular areas of enhancement in the left parietooccipital area
associated with marked brain edema, left-to-right shift, and
mass effect (Figure 2). 
The patient was taken to surgery, where a firm avascular
mass was found beneath a 0.5-cm layer of softer gliotic corti-
cal tissue. Frozen sections showed lymphohistiocytic infiltrates
with granuloma formation. Specimens for cultures and
histopathologic examination were obtained. Bacterial, fungal,
and acid-fast bacilli stains were negative. Final histopathologic
examination showed numerous granulomas with multinucleat-
ed giant cells but no organisms (Figure 1).
Serologic test results for Brucella,  T. gondii, and Taenia
soleum were negative. On postoperative day 8, mycobacteria
cultures (BacT/ALERT MP; Organon Teknika Corp., Durham,
NC) showed growth of a gram-negative coccobaccillus, later
confirmed as Brucella spp. Treatment with rifampin, doxycy-
cline, and intravenous gentamicin was begun. After 1 week, the
gentamicin was discontinued per current recommendations, and
trimethoprim-sulfamethoxazole was started. Follow-up imag-
ing 7 months later demonstrated resolution of the enhancing
areas and edema, with residual areas of brain atrophy (Figure
2). The patient’s vision improved, but some visual acuity
deficits persisted. Anti-brucella therapy continued for 1 year. 
The patient lived in a small town 7 hours from Lima and
had not traveled outside of the country before coming to the
United States. His diet included regular consumption of queso
fresco and occasional ceviche but no other raw meats. He
reported no direct contact with marine mammals and seldom
visited the Peruvian coast.
Materials and Methods
Bacterial isolates were identified as Brucella spp. by using
a real-time, 5′ exonuclease (TaqMan) assay, based on a well-
characterized polymerase chain reaction (PCR) assay that tar-
gets a highly-conserved 223-bp region of a gene (bcsp31)
encoding a 31-kDa immunogenic B. abortus protein (10).
Amplified product was detected through the design of a dual-
labeled hybridization probe, 5′-CCGGTGCCGTTATAGGCC-
CAATAGG (5′, 6-carboxyfluorescein label; 3′, 6- carboxyte-
tramethylrhodamine label). Real-time detection of amplified
product was performed with a LightCycler (Roche Applied
Science, Indianapolis, IN) by using the following amplification
parameters: 2 min at 50°C, 10 min at 95°C, and 30 cycles of
95°C for 10 s and 60°C for 30 s. Fluorescence was monitored
at 530 nm. 
After identifying a bacterial isolate as Brucella spp., we
attempted further classification to the species level by using
real-time PCR assays to detect B. abortus, B. melitensis, and
biovar 1 of B. suis (11). We used a PCR assay targeting the
bp26 gene, performed as described by Cloeckaert et al. (12), to
discriminate between terrestrial strains and marine mammal
strains of Brucella.
Partial DNA sequencing of omp2a was also used for
Brucella isolate classification (13). Amplification and sequenc-
ing of a 519-bp region of the omp2a gene were performed by
using the primers 5′-GGGTGGCGAAGACGTTGACAA and
5′-AACCGTTGGCGCCCTATGC. Dye terminator cycle
sequencing (Applied Biosystems, Foster City, CA) was per-
formed according to the manufacturer’s recommendation; the
sequencing reactions were analyzed on an ABI 377 DNA
sequencer.
Results
Histopathology
Both cases demonstrated well-developed, granulomatous
inflammation with accompanying astrogliosis. Patient 1
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Figure 2. Axial MRI (magnetic resonance imaging) from patient 2
obtained when first seen in Peru (April 21, 2001), before surgical biop-
sy in the United States (September 21, 2001), and 7 months after start
of treatment (June 7, 2002). The top images are postgadolinium-
enhanced, T1-weighted images, which demonstrate resolution of one of
the irregular areas of enhancement over time. The bottom images are
T2-weighted images (image from April 21 is from a fluid attenuated
inversion recovery [FLAIR] sequence), which demonstrate the exten-
sive brain edema associated with these lesions. The right bottom image
shows resolution of the brain edema but persistent brain atrophy. showed dense perivascular lymphoplasmacytic infiltrates with
nonnecrotizing granulomas containing epithelioid and spindle-
shaped macrophages and occasional well-formed giant cells
(Figure 1). Tissue Gram, Fite, and silver methenamine stains
showed no definite organisms. Patient 2 showed florid granulo-
matous inflammation with large areas of epithelioid and spin-
dle-shaped histiocytes containing foci of necrosis surrounded
by dense chronic inflammation (Figure 1). Giemsa, Steiner,
Warthin-Starry, tissue Gram, Grocott methenamine silver, and
Fite stains did not detect organisms. Giant cells were not
observed in patient 2. Masson trichrome stain showed accom-
panying marked fibrosis. 
Molecular Microbiology
Presumptive Brucella isolate 01A09163 was isolated from
the brain biopsy of patient 2 and was submitted to the
Microbial Diseases Laboratory (the microbiology reference
laboratory for the State of California) for laboratory confirma-
tion. Identification of Brucella spp. was confirmed by a 5′-
exonuclease assay that targets a 223-bp region of the bcsp31
gene. Isolates confirmed as Brucella were then further classi-
fied as B. abortus, B. melitensis, or B. suis biovar 1 by the real-
time PCR assays described by Redkar et al. (11). Strain
01A09163 tested negative by these assays, indicating that this
isolate likely represented a different species of Brucella. 
Areview of Microbial Diseases Laboratory records showed
a second Brucella strain, 85A05748, associated with an intrac-
erebral granuloma. This strain was isolated in 1985 from the
brain lesion of patient 1. Given the clinical similarities in these
two cases, strain 85A05748 was tested by PCR. Like strain
01A09163, strain 85A05748 was negative in the B. abortus, B.
melitensis, and B. suis biovar 1 assays. 
To aid in the identification of these strains to the species
level, a portion of the omp2a locus was amplified and
sequenced. Between the two strains, the omp2a sequences were
identical and indicated that the two strains were likely of the
same species. A BLAST search of the National Center for
Biotechnology Information databases established that the
omp2a sequence of these two strains was identical to the
omp2a sequence derived from Brucella sp. B2/94 (GenBank
accession no. AF300819), a marine mammal strain of Brucella
isolated from a common seal (7). Compared to other Brucella
strains, one or more polymorphisms were noted in the omp2a
sequence of 01A09163 and 85A05748. This observation sug-
gested that strains 01A09163 and 85A05748 were most close-
ly related to a marine mammal strain, rather than a terrestrial
strain, of Brucella. 
To verify that strains 01A09163 and 85A05748 were genet-
ically related to strains of Brucella derived from marine mam-
mals, we performed a PCR assay targeting the bp26 gene (12).
Marine mammal strains of Brucella possess an IS711 element
immediately downstream of bp26, whereas the sequence of ter-
restrial strains does not. Consequently, amplification of the
region surrounding bp26 yields a much larger DNA fragment
for marine mammal strains as compared to the amplification
product produced by terrestrial strains of Brucella. As shown in
Figure 3, amplification of the bp26 gene from strains
01A09163 and 85A05748 yielded a 1,900-bp product that was
diagnostic for marine mammal strains of Brucella.
Amplification of bp26 from a terrestrial strain, B. abortus, pro-
duced the expected 1,024-bp product. 
Discussion
Our report of serious central nervous system disease caused
by a marine mammal Brucella strain confirms that these organ-
isms can cross over from their primary hosts to humans in a
community setting. Brucella infections have been documented
in studies of marine mammals that died after being stranded
ashore (7,8). Although a formal nomenclature has not yet been
established, evidence is sufficient to support the expansion of
the  Brucella genus. Studies of DNA polymorphisms at the
omp2 locus indicate that more than one species may be repre-
sented in this group (8). When the proposed classification
scheme of Cloeckaert et al. (8) is used, partial omp2a sequence
suggests that the two isolates from our study are most closely
related to B. pinnipediae, a seal strain of Brucella.
Despite a more than 15-year separation, these cases have a
number of epidemiologic, clinical, and histopathologic similar-
ities. Both patients had recently immigrated from Peru. They
denied significant exposure to marine mammals.
Neuroimaging and pathology studies were very similar.
Marked granulomatous inflammation was observed in each
biopsy, but histopathologic studies did not reveal the organism
in tissue sections. Definitive diagnosis was subsequently made
by bacterial isolation. 
Notably, Brucella spp. antibody was not elevated in patient
2. Despite his prolonged duration of illness and extensive cen-
tral nervous system involvement, the patient’s steroid medica-
tions, unknown host factors, or low immunogenicity of marine
mammal strains may be responsible for his lack of serologic
response, emphasizing the importance of direct isolation.
Neurobrucellosis develops in <5% of patients with Brucella
infection (1). The most frequent clinical syndromes associated
with acute infection are meningitis or meningoencephalitis
(1–3). Mass lesions within the brain parenchyma are extremely
uncommon but have been documented radiographically (6) and
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Figure 3. Amplification of bp26 from marine mammal and terrestrial
strains of Brucella. The amplification products were electrophoresed on
a 1% agarose gel and stained with ethidium bromide. Lane 1, strain
01A09163; lane 2, strain 85A05748; lane 3, B. abortus ATCC 23448;
lane 4, no template control. DNA ladder is shown in Lane M. pathologically (14). Patient 1 underwent granuloma resection
before medical therapy and did not have relapse of infection.
Patient 2 was treated with medical therapy. Such infections,
despite widespread central nervous system extension, could
possibly be treated medically, reducing potential long-term
neurologic complications of resection. Furthermore, the indo-
lent nature of these infections suggests that early detection and
treatment could prevent the long-term consequences of a
chronic intracranial inflammatory process.
These cases raise important issues about the epidemiology
of human Brucella infection related to transmission of nonter-
restrial strains. In the absence of a direct association with
marine mammals, more traditional zoonotic sources of infec-
tion may be involved. Experimental infection of dairy cattle
with a marine mammal strain of Brucella has been document-
ed (15). Given the extensive Peruvian coastline, marine mam-
mal strains of Brucella could conceivably have been transmit-
ted to domestic animals and wildlife that reside nearby. 
What degree of pathogenicity these strains may have in
human infection is unclear. Further study of infection in both
humans and marine mammals is needed to characterize the
spectrum of disease and the potential for communicability.
Such studies may be facilitated by the implementation of new
laboratory tests to rapidly identify marine mammal strains of
Brucella. 
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